Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New cream shows promise for rare skin condition

NCT ID NCT03972592

First seen Feb 15, 2026 · Last updated May 23, 2026 · Updated 9 times

Summary

This study tested a cream containing sirolimus on rare skin blisters caused by faulty lymph vessels. Fifty-five children and adults applied the cream to one area and a placebo to another for 12 weeks. Doctors measured improvement using a standard skin score. The goal was to see if the cream reduces oozing, bleeding, and pain better than placebo.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for VASCULAR MALFORMATIONS are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • ANGERS

    Angers, France

  • BORDEAUX

    Bordeaux, France

  • CAEN

    Caen, France

  • DIJON

    Dijon, France

  • LYON AD

    Bron, France

  • LYON PED

    Bron, France

  • Lariboisiere

    Paris, France

  • Marseille

    Marseille, France

  • Montpellier

    Montpellier, France

  • NANCY

    Vandœuvre-lès-Nancy, France

  • NANTES

    Nantes, France

  • NECKER

    Paris, France

  • NICE

    Nice, France

  • QUIMPER

    Quimper, France

  • RENNES

    Rennes, France

  • TOULOUSE

    Toulouse, France

  • TOURS

    Tours, France

Conditions

Explore the condition pages connected to this study.